Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Shares of Novo Nordisk Inc. (NYSE: NVO) are trading lower Tuesday after a new study raised concerns about a potential link ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

but also capitalizes on the same biological mechanisms responsible for the success of popular weight-loss drugs. Semaglutide ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

The effectiveness of the HonXi SMGT-GLP-1 Nano Microneedle Patch lies in its unique mechanism of action that closely resembles the natural functions of GLP-1 in the body. GLP-1 is a hormone produced ...

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

The average representation of GLP-1 drugs used for weight loss in total annual claims was 10.5% for 2025, an increase over ...

First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of obesity-related cancers, compared with weight-loss surgery, researchers report ...

Despite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 ...

GLP-1 use appeared associated with reduced risk for various blood cancers in patients with type 2 diabetes. The mechanism behind this association remains unknown and warrants further investigation.